Figures & data
Table 1 Clinical Characteristics of the Patients with DTR vs Non-DTR Klebsiella pneumoniae
Figure 1 (A) Department distribution of the DTR-Kp-infected patients. (B) Sample type distribution of the DTR-Kp strains. (C) Resistance category distribution of all the enrolled Kp isolates.
![Figure 1 (A) Department distribution of the DTR-Kp-infected patients. (B) Sample type distribution of the DTR-Kp strains. (C) Resistance category distribution of all the enrolled Kp isolates.](/cms/asset/4ca440bc-993f-457b-a294-174e3749b667/didr_a_377064_f0001_c.jpg)
Figure 2 Percentage of the hypervirulent Klebsiella pneumoniae (hvKp) strains among the identified DTR-Kp strains from January 2020 to March 2021.
![Figure 2 Percentage of the hypervirulent Klebsiella pneumoniae (hvKp) strains among the identified DTR-Kp strains from January 2020 to March 2021.](/cms/asset/0c680aa3-7119-4084-9d75-d60be3ba3331/didr_a_377064_f0002_c.jpg)
Figure 3 Genomic distribution of the DTR Klebsiella pneumoniae strains. Red: antimicrobial resistance genes. Blue: Virulence genes.
![Figure 3 Genomic distribution of the DTR Klebsiella pneumoniae strains. Red: antimicrobial resistance genes. Blue: Virulence genes.](/cms/asset/7200297a-14a1-4364-8e9b-fa91cb3f4fb6/didr_a_377064_f0003_c.jpg)
Figure 4 Kaplan–Meier curves for all-cause 30-day mortality. Statistical significance was determined by the Log rank test.
![Figure 4 Kaplan–Meier curves for all-cause 30-day mortality. Statistical significance was determined by the Log rank test.](/cms/asset/dd6c80cd-17f9-4a86-99cc-0830ab88d345/didr_a_377064_f0004_c.jpg)
Table 2 Risk Factors for Death
Table 3 Risk Factors for DTR-Kp Infection